Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 15;37(17):e9596.
doi: 10.1002/rcm.9596.

Review of fragmentation of synthetic single-stranded oligonucleotides by tandem mass spectrometry from 2014 to 2022

Affiliations
Review

Review of fragmentation of synthetic single-stranded oligonucleotides by tandem mass spectrometry from 2014 to 2022

Fabien Hannauer et al. Rapid Commun Mass Spectrom. .

Abstract

The fragmentation of oligonucleotides by mass spectrometry allows for the determination of their sequences. It is necessary to understand how oligonucleotides dissociate in the gas phase, which allows interpretation of data to obtain sequence information. Since 2014, a range of fragmentation mechanisms, including a novel internal rearrangement, have been proposed using different ion dissociation techniques. The recent publications have focused on the fragmentation of modified oligonucleotides such as locked nucleic acids, modified nucleobases (methylated, spacer, nebularine and aminopurine) and modification to the carbon 2'-position on the sugar ring; these modified oligonucleotides are of great interest as therapeutics. Comparisons of different dissociation techniques have been reported, including novel approaches such as plasma electron detachment dissociation and radical transfer dissociation. This review covers the period 2014-2022 and details the new knowledge gained with respect to oligonucleotide dissociation using tandem mass spectrometry (without priori sample digestion) during that time, with a specific focus on synthetic single-stranded oligonucleotides.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Structures of nucleobases and oligonucleotide. Reproduced from Hannauer et al.
FIGURE 2
FIGURE 2
From left to right: structures of LNA, PNA and morpholino phosphoroamidate.
FIGURE 3
FIGURE 3
McLuckey nomenclature for oligonucleotide fragmentation.
FIGURE 4
FIGURE 4
Fragmentation pathway for the formation of a‐B and w in DNA sequences. Adapted from Wan et al.
FIGURE 5
FIGURE 5
Dissociation pathway for the formation of c and y in RNA sequence with (A, B) two different mechanisms. Adapted from Tromp and Schürch.
FIGURE 6
FIGURE 6
Structures of different modified nucleosides. Y: 2‐aminopurine; D: 2′‐deoxyribose spacer; R: ribose spacer; N: nebularine; a′: 2′‐OCHE adenosine; P: propanediol linker. Analysed in Riml et al.
FIGURE 7
FIGURE 7
Proposed mechanism for phosphodiester backbone bond cleavage for [M + nH] n+ ions of RNA in CID (off‐resonance). Reproduced from Fuchs et al.
FIGURE 8
FIGURE 8
(A) Proposed mechanism for the release of NCO upon CID (on‐resonance) of highly negatively charged oligonucleotide. (B) Postulated mechanism for metaphosphate excision as subsequent reaction to NCO and water loss. Reproduced from Nyakas et al.
FIGURE 9
FIGURE 9
Structure of homo‐DNA.
FIGURE 10
FIGURE 10
Structures of the methylcytidine, methyladenosine, methylguanosine, methyluridine and thiouridine monophosphate isomers analysed in Jora et al. and Li et al.
FIGURE 11
FIGURE 11
Proposed CID (on‐resonance) pathways for (A) methyladenosine, (B–D) methylguanosine, (E) methylcytidine and (F) methyluridine adapted from Li et al. Original assignment of loss of NH replaced with re‐interpretation as loss of CH3 as denoted by *, with consequent new proposals of product ion structures.
FIGURE 12
FIGURE 12
Proposed dissociation products of ETD in positive ion ESI where w or d ion carries a negative charge and the complementary product ion harbours a positive charge. Reproduced from Hari et al.
FIGURE 13
FIGURE 13
Proposed mechanism for the formation of the product ions d and w by RTD. Reproduced from Calderisi et al.
FIGURE 14
FIGURE 14
Proposed mechanism for the generation of rearranged [phosphopurine] and y‐B ions. Adapted from Harper et al.

Similar articles

Cited by

References

    1. Lundin KE, Gissberg O, Smith CIE. Oligonucleotide therapies: the past and the present. Hum Gene Ther. 2015;26(8):475‐485. doi:10.1089/hum.2015.070 - DOI - PMC - PubMed
    1. Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020;19(10):673‐694. doi:10.1038/s41573-020-0075-7 - DOI - PMC - PubMed
    1. Claborn MK, Stevens DL, Walker CK, Gildon BL. Nusinersen: A treatment for spinal muscular atrophy. Ann Pharmacother. 2019;53(1):61‐69. doi:10.1177/1060028018789956 - DOI - PubMed
    1. Lim KRQ, Maruyama R, Yokota T. Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017;11:533‐545. doi:10.2147/DDDT.S97635 - DOI - PMC - PubMed
    1. Ling H, Fabbri M, Calin GA. MicroRNAs and other non‐coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847‐865. doi:10.1038/nrd4140 - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources